Status of glycemic control in elderly patients with cognitive impairment treated by general practitioners relative to the glycemic targets recommended for elderly patients by the Japan Diabetes Society/Japan Geriatrics Society Joint Committee: A retrospective analysis

Taiki Sugimoto; Kenji Toba; Takashi Sakurai

doi:10.1111/jdi.12786

Status of glycemic control in elderly patients with cognitive impairment treated by general practitioners relative to the glycemic targets recommended for elderly patients by the Japan Diabetes Society/Japan Geriatrics Society Joint Committee: A retrospective analysis

J Diabetes Investig. 2018 Sep;9(5):1230-1232. doi: 10.1111/jdi.12786. Epub 2018 Jun 14.

Authors

Taiki Sugimoto^{1

2

3

4}, Kenji Toba¹, Takashi Sakurai¹

Affiliations

¹ Center for Comprehensive Care and Research on Memory Disorders, National Center for Geriatrics and Gerontology, Obu, Japan.
² Medical Genome Center, National Center for Geriatrics and Gerontology, Obu, Japan.
³ Department of Community Health Sciences, Graduate School of Health Sciences, Kobe University, Kobe, Japan.
⁴ Japan Society for the Promotion of Science, Tokyo, Japan.

Abstract

We investigated the status of glycemic control in elderly patients with cognitive impairment relative to the glycemic targets recommended for elderly patients by the Japan Diabetes Society (JDS)/Japan Geriatrics Society (JGS) Joint Committee. Our results indicated that use of drugs associated with severe hypoglycemia led to excessively lower HbA1c in many patients in categories II and III.

Publication types

Letter

MeSH terms

Aged
Aged, 80 and over
Cognitive Dysfunction / blood*
Cognitive Dysfunction / chemically induced
Cognitive Dysfunction / epidemiology
Diabetes Mellitus / blood*
Diabetes Mellitus / drug therapy
Diabetes Mellitus / epidemiology
Female
General Practitioners* / trends
Glycated Hemoglobin / metabolism
Glycemic Index / drug effects
Glycemic Index / physiology*
Humans
Hypoglycemic Agents / adverse effects*
Hypoglycemic Agents / pharmacology
Japan / epidemiology
Male
Retrospective Studies
Societies, Medical* / trends
Treatment Outcome

Substances

Glycated Hemoglobin A
Hypoglycemic Agents
hemoglobin A1c protein, human